BRCA1, BRCA2 and CHEK2 (1100 del C) Germline Mutations in Hereditary Breast and Ovarian Cancer Families in South India

Asian Pacific Journal of Cancer Prevention

Volumn 4, Issue 3, 2003, Pages 203-208

  Rajkumar, Thangarajan ^a   Soumittra, Nagasamy ^b   Nancy, Nirmala Karunakaran ^b   Swaminathan, Rajaraman ^b   Sridevi, Veluswami ^b   Shanta, Vishwanathan ^b  

^a CANCER INSTITUTE WIA   (India)

^b NONE

Author keywords

BRCA1; BRCA2; CHEK2 (del1100); DHPLC; Hereditary breast or ovarian cancer; India

Indexed keywords

CHECKPOINT KINASE 2; PROTEIN KINASE; PROTEIN SERINE THREONINE KINASE;

ADULT; ARTICLE; BREAST TUMOR; FEMALE; GENETICS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INDIA; MUTATION; OVARY TUMOR; PEDIGREE; TUMOR SUPPRESSOR GENE;

ADULT; BREAST NEOPLASMS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; GENES, BRCA1; GENES, BRCA2; GERM-LINE MUTATION; HUMANS; INDIA; OVARIAN NEOPLASMS; PEDIGREE; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES;

EID: 0642340839     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Bell DW, Varley JM, Szydlo TE, et al (1999). Heterozygous germline hCHK2 mutations in Li- Fraumeni Syndrome. Science, 286, 2528-31.
2. Blesa JR, Garcia JA, Ochoa E (2000). Frequency of germ-line BRCA1 mutations among Spanish families from a Mediterranean area. Hum Mutat, 15, 381-2.
3. Choy YS, Dabora SL, Hall F, et al (1999). Superiority of denaturing high performance liquid chromatography over single-stranded conformation and conformation-sensitive gel electrophoresis for mutation detection in TSC2. Ann Hum Genet, 63, 383-91.
4. Couch PJ, Deshano ML, Blackwood MA, et al (1997). BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N Engl J Med, 336,1409-15.
5. Gajalakshmi V, Shanta V, Swaminathan R (2001). Cancer Registration in India. History of Population Based Cancer Registries in India. Asian Pac J Cancer Prevent, IACR Suppl, 2, 13-20.
6. Gross E, Arnold N, Goette J, Schwarz-Boeger U, Kiechle M (1999). A comparison of BRCA1 mutation analysis by direct sequencing, SSCP, DHPLC. Hum Genet, 105, 72-8.
7. Haffty BG, Harrold E, Khan AJ, et al (2002). Outcome of conservatively managed early-onset breast cancer by BRCA1/2 status. Lancet, 359,1471-7.
8. Hedenfalk I, Duggan D, Chen Y, et al (2001). Gene expression profiles in hereditary breast cancer. N Engl J Med, 344, 539-48.
9. Kumar BV, Lakhotia S, Ankathil R, et al (2002). Germline BRCA1 mutation analysis in Indian breast/ovarian cancer families. Cancer Biol Ther, 1, 18-21.
10. Lee SB, Kim SH, Bell DW, et al (2001). Destabilisation of CHK2 by a missense mutations associated with Li- Fraumeni Syndrome. Cancer Res, 61, 8062-7.
11. Marsh DJ, Theodosopoulos G, Howell V, et al (2001). Rapid mutation scanning of genes associated with familial cancer syndromes using denaturing high- performance liquid chromatography. Neoplasia, 3, 236-44.
12. Peto J, Collins N, Barfoot R, et al (1999). Prevalence of BRCA1 and BRCA2 gene mutations in patients with early- onset breast cancer. J Natl Cancer Inst, 91, 943-9.
13. Pierce L (2002) Radiotherapy of breast cancer in BRCA1/BRCA2 carriers: clinical issues and management dilemmas. Semin Radiat Oncol,12: 352-61.
14. Saxsena S, Szabo CI, Chopin S, et al (2002). BRCA1 and BRCA2 in Indian breast cancer patients. Hum Mutat, 20, 473-4.
15. Schoumacher F, Glaus A, Mueller H, et al (2000). BRCA1/2 mutations in Swiss patients with familial or early-onset breast and ovarian cancers. Swiss Med Wkly, 131, 223-6.
16. Shanta V, Gajalakshmi V, Swaminathan R (2001). Cancer incidence in Chennai, India: Patterns and trends during 1984-1998. Population Based Cancer Registry: Chennai, Cancer Institute (WIA), Chennai.
17. Speigelman JI, Mindrinos MN, Oefner PJ (2000). High -accuracy DNA sequence variation screening by DHPLC. Biotechniques, 29, 1084-90.
18. The CHEK2 breast cancer consortium (2002). Low- penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1or BRCA2 mutations. Nat Genet, 31, 55-9.
19. Verhoog LC, Brekelmans CTM, Seynaeve C, et al (1998). Survival and tumor characteristics of breast-cancer patients with germline mutations of BRCA1. Lancet, 351, 316-20.
20. Wagner T, Lyonnet DS, Fleischmann E, et al (1999). Denaturing high performance liquid chromatography detects reliably BRCA1 and BRCA2 mutations. Genomics, 62, 369-76.
21. Wagner TMU, Möslinger RA, Muhr D, et al (1998). BRCA1- related breast cancer in Austrian breast and ovarian cancer families: specific BRCA1 mutations and pathological characteristics. Int J Cancer, 77, 354-60.